Genomic Differences Between “Primary” and “Secondary” Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy

BACKGROUND: Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) is the standard of care for patients with muscle-invasive bladder cancer (MIBC). It is unknown whether this treatment strategy is appropriate for patients who progress to MIBC after treatment for prior non...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Urol
Autors principals: Pietzak, Eugene J., Zabor, Emily C., Bagrodia, Aditya, Armenia, Joshua, Hu, Wenhuo, Zehir, Ahmet, Funt, Samuel, Audenet, Francois, Barron, David, Maamouri, Noelia, Li, Qiang, Teo, Min Yuen, Arcila, Maria E., Berger, Michael F., Schultz, Nikolaus, Dalbagni, Guido, Herr, Harry W., Bajorin, Dean F., Rosenberg, Jonathan E., Al-Ahmadie, Hikmat, Bochner, Bernard H., Solit, David B., Iyer, Gopa
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6339572/
https://ncbi.nlm.nih.gov/pubmed/30290956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2018.09.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars